Journal of Clinical Endocrinology & Metabolism, Vol 80, 3377-3380, Copyright © 1995 by Endocrine Society

ARTICLES

Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus

DB Thompson, WS Samowitz, S Odelberg, RK Davis, J Szabo and H Heath 3rd
Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City 84132, USA.

Inactivating mutations of the parathyroid cell calcium receptor (CaR) gene cause one form of familial benign/hypocalciuric hypercalcemia, and in homozygous form, cause neonatal severe primary hyperparathyroidism with parathyroid hyperplasia. Thus, we postulated that partial or total loss of CaR function might contribute to calcium insensitivity or even stimulate cell proliferation in sporadic parathyroid adenomas (PAds). To examine this possibility, we sought loss of heterozygosity (LOH) for markers flanking the CaR locus (3cen-3q21) in 35 PAds. We used 16 highly-polymorphic PCR-based markers in paired normal and tumor DNA, extracted from slices of archived surgical specimens. Nineteen to 24 of the DNA pairs were informative with at least one marker. In two informative pairs, we found LOH for markers D3S1303, D3S1267, or D3S1269, which are tightly-linked with and flank the CaR locus. In one tumor, deletion mapping confined the lost area between D3S1271 and D3S1238 (41.7 centimorgans, cM). In the other tumor, LOH spanned most of chromosome 3, ranging at least from D3S1307 to D3S1311 (271.4 cM). LOH was confirmed by repetition of the experiments and quantified by phosphorimaging. Thus, we found LOH encompassing the CaR locus in approximately 10% of sporadic PAds. These data are consistent with the hypothesis that loss of CaR function may occur in PAds, with functional consequences for calcium sensitivity and cell proliferation.

This article has been cited by other articles:

				L. Canaff and G. N. Hendy Human Calcium-sensing Receptor Gene. VITAMIN D RESPONSE ELEMENTS IN PROMOTERS P1 AND P2 CONFER TRANSCRIPTIONAL RESPONSIVENESS TO 1,25-DIHYDROXYVITAMIN D J. Biol. Chem., August 9, 2002; 277(33): 30337 - 30350. [Abstract] [Full Text] [PDF]

				E. Szabo, T. Carling, O. Hessman, and J. Rastad Loss of Heterozygosity in Parathyroid Glands of Familial Hypercalcemia with Hypercalciuria and Point Mutation in Calcium Receptor J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3961 - 3965. [Abstract] [Full Text] [PDF]

				S. Hemmer, V.-M. Wasenius, C. Haglund, Y. Zhu, S. Knuutila, K. Franssila, and H. Joensuu Deletion of 11q23 and Cyclin D1 Overexpression Are Frequent Aberrations in Parathyroid Adenomas Am. J. Pathol., April 1, 2001; 158(4): 1355 - 1362. [Abstract] [Full Text] [PDF]

				F. Cetani, A. Picone, P. Cerrai, E. Vignali, S. Borsari, E. Pardi, P. Viacava, A. G. Naccarato, P. Miccoli, O. Kifor, et al. Parathyroid Expression of Calcium-Sensing Receptor Protein and in Vivo Parathyroid Hormone-Ca2+ Set-Point in Patients with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4789 - 4794. [Abstract] [Full Text]

				R. Mihai and J. R. Farndon Parathyroid disease and calcium metabolism Br. J. Anaesth., July 1, 2000; 85(1): 29 - 43. [Full Text] [PDF]

				M. Sarquis, E. Friedman, W. L. Boson, R. S. Gomez, A. F. Dias, and L. De Marco Microsatellite Instability in Sporadic Parathyroid Adenoma J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 250 - 252. [Abstract] [Full Text]

				A. M. Parfitt, Q. Wang, and S. Palnitkar Rates of Cell Proliferation in Adenomatous, Suppressed, and Normal Parathyroid Tissue: Implications for Pathogenesis J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 863 - 869. [Abstract] [Full Text]